Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia : results from Cancer and Leukemia Group B (CALGB 8461)

• BYRD JC

収録刊行物

• Blood

  Blood 100 4325-4336, 2002

詳細情報

• CRID: 1573105975416508032
• NII論文ID: 10021255539
• データソース種別:
  • CiNii Articles